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ABSTRACT
Background. Acute kidney injury (AKI) is associated with decreased survival, future risk of chronic kidney disease and longer
hospital stays. Electronic alerts (e-alerts) for AKI have been introduced in the UK in order to facilitate earlier detection and
improve management. The aim of this study was to establish if e-alerts in primary care were acted on by examining timing
of repeat creatinine testing.
Methods. The National Health Service England Acute Kidney Injury electronic alert algorithm was introduced in April 2015
across both primary and secondary care in NHS Tayside accompanied by a programme of education. Data from a 12-month
period (2012) predating introduction of the e-alerts were compared with a 12-month period following implementation of e-
alerts for AKI. Biochemistry testing following the AKI episode, timing of repeat tests and numbers of patients hospitalized
within 7 days of episode were compared between the two time periods.
Results. During the 12 months after e-alert introduction, 9781 AKI e-alerts were generated. Of these, 1460 (14.9%) alerts were
generated in primary care. Median duration to repeat blood testing for these primary care alerts was 5 days for AKI Stage 1
[interquartile range (IQR) 2–10], 2 days for Stage 2 (IQR 1–5) and 1 day (IQR 0–2) for Stage 3. During 2012 (prior to e-alert
implementation) 8812 AKI episodes were identified. Of these, 2650 tests (30.1%) were requested by primary care staff.
Median duration to repeat creatinine testing was longer: 55 days (IQR 20–142) for Stage 1, 38 days (IQR 15–128) for Stage 2
was and 53 days (IQR 20–137) for Stage 3. More patients had biochemistry tests repeated within 7 days of AKI onset, pre-alert
implementation; 252 (9.5%) versus 857 (58.7%) (P<0.001). Rates of hospitalization within 7 days of AKI increased from 342
(12.9%) pre-implementation to 372 (25.5%) post-implementation (P<0.001).
Conclusions. Within primary care, e-alert implementation was associated with higher rates of creatinine monitoring, but
also higher rates of hospitalization.
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INTRODUCTION
Acute kidney injury (AKI) is common, affecting 15% of hospital-
ized patients, with a significant proportion originating in the
community [1, 2]. It is associated with increased length of hospi-
tal stays, higher healthcare resource utilization and mortality [3,
4]. Identification is a key first step in implementing strategies to
prevent more severe AKI. Identifying those patients at increased
risk of AKI whilst they are in the community may facilitate ear-
lier detection and hence timely implementation of prevention
and mitigation measures such as medication review, thus poten-
tially avoiding both worsening of AKI and hospital admission.
Electronic alerts (e-alerts) for AKI are increasingly being
implemented in hospitals to facilitate earlier identification.
Implementation of e-alerts for AKI in secondary care is manda-
tory in England and Wales, with extension to primary care
planned. There have been a number of studies evaluating the
impact of e-alerts for AKI in hospitalized patients, with conflict-
ing findings. A recent meta-analysis showed that e-alerts did
not improve survival or reduce utilization of renal replacement
therapy [5]. However, the context in which alerts were imple-
mented and the processes of care were variable. In contrast,
there is very little work examining the impact of introducing
AKI e-alerts to primary care health systems.
E-alerts for AKI were implemented in both primary and sec-
ondary care in the National Health Service (NHS) Tayside region
of Scotland in April 2015, accompanied by a programme of educa-
tion to raise awareness. The aim of our study was to measure the
impact of e-alerts in primary care by comparing whether repeat
biochemistry sampling was performed and the time frame over
which it was performed in patients with AKI pre- and post-alert
implementation. Rates of hospitalization were also examined.
MATERIALS ANDMETHODS
Study population
The study population comprised two cohorts: all adults over
18 years of age resident in the NHS Tayside region of Scotland
with AKI generated in primary care between 1 January 2012 and
the 31 December 2012 and between 30 April 2015 and 1 May
2016. The year 2012 was selected arbitrarily to allow comparison
prior to e-alert implementation. Patients with AKI detected from
a biochemistry sample requested from hospital locations, out-
patient clinics and community hospitals were excluded, limiting
the cohort to AKI detected in samples requested by primary care.
Data sources
Data from 2012, prior to the implementation of e-alerts, were
linked using the Health Informatics Centre (HIC) at the
University of Dundee [6]. HIC enables anonymized health record
linkage from the population of Tayside (400 000), Scotland, using
a unique identifying Community Health Index (CHI) number.
Data were linked between the following data sets: Scottish
Morbidity Record of hospital admissions (SMR01), laboratory
results and the Scottish Care Initiative-Diabetes Collaboration.
Age, sex and heart failure data were obtained from SMR01.
Creatinine measurements were obtained from the biochemistry
laboratory system and the presence of diabetes from the
Scottish Care Initiative-Diabetes Collaboration system.
The NHS Tayside biochemistry laboratory reporting system
was used to identify all e-alerts generated between 30 April
2015 and 1 May 2016. Data on age, sex, stage of AKI, diabetes,
heart failure and repeat biochemistry testing following the
generation of the e-alert, and timing of this, and hospital admis-
sion were collated.
Outcomes
AKI was defined using the NHS England algorithm based on the
Kidney Disease: Improving Global Outcomes criteria [7, 8].
Baseline was taken as either: (i) the median creatinine level in
the period between 8 and 365 days prior to the index creatinine
measurement; (ii) the lowest level in the period 0–7 days prior to
the index measurement; or (iii) the lowest level between 0 and
2 days prior to the index measurement. If several alerts were
generated, the first alert was included. A further alert following
recovery to baseline renal function was treated as a new epi-
sode. The same definition based on the NHS England algorithm
was applied to the 2012 cohort.
E-alerts were implemented in both primary and secondary
care in April 2015 in Tayside, with education delivered to both
areas. Real-time alerts are generated on the laboratory reporting
system. Following an e-alert, clinicians are prompted to inter-
vene and signposted to local AKI guidelines—either hospital or
primary care guidelines dependent on where the sample was
requested. E-mails are sent to requesting clinicians for AKI
Stages 2 and 3.
Statistical methods
Data were analysed in Microsoft Excel and SPSS v24 (IBM, Armonk,
New York, USA). Categorical variables are presented as percen-
tages. Groups were compared using Pearson chi-squared tests.
Ethical statement
Anonymized record linkage was conducted according to HIC
Standard Operating Procedure (SOP). The Tayside Research
Ethics Committee does not require submission of individual
studies that follow this SOP. We obtained permission from NHS
Tayside’s Caldicott Guardian to examine patients with e-alerts.
RESULTS
Demographics
A flowchart outlining formation of study cohorts is shown in
Figure 1. Demographics of patients’ pre- and post-alert imple-
mentation are shown Table 1.
There were 8812 AKI episodes in 2012 over a 12-month pe-
riod (1 January 2012 to 31 December 2012; pre-alert implementa-
tion). Of these, 2650 (30.1%) originated in primary care with 2483
(93.7%) Stage 1 AKI, 110 (4.2%) Stage 2 and 57 (2.1%) Stage 3 AKI.
Following implementation of e-alerts, there were 9978 AKI
episodes e-alerts during the 12-month study period (30 April
2015–1 May 2016). A total of 150 alerts were excluded due to
false positives, dialysis patients and same AKI episode. As a
proportion of the total alerts generated, fewer alerts were gener-
ated in primary care: 1460 (14.8%) compared with 2650 (30.1%),
P< 0.001. Of these, 1167 (79.9%) were Stage 1 AKI, 181 (12.4%)
Stage 2 and 112 (7.7%) Stage 3 AKI.
Actions in response to AKI
Number of patients with repeat creatinine testing within 7 days
of an AKI episode and number of patients admitted to hospital
within 7 days of an AKI episode before and after implementa-
tion of e-alerts are shown in Table 2. Repeat creatinine testing
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was higher across all stages of AKI following e-alert introduc-
tion. In 2012, the rate of repeat testing within 7 days was 9.4,
11.8 and 7.0% for Stages 1, 2 and 3, respectively, compared with
53.4, 79.6 and 80.4% for Stages 1, 2 and 3 following
implementation of e-alerts in 2015, P< 0.001. In 2012, the median
duration to repeat creatinine testing for AKI Stage 1 was 55 days
[interquartile range (IQR) 20–142], for AKI Stage 2 was 38 days (IQR
15–128) and for AKI Stage 3 was 53 days (IQR 20–137).
Median duration to repeat creatinine testing in 2015–16 was
5 days for AKI Stage 1 (IQR 2–10), 2 days for AKI Stage 2 (IQR 1–5)
and 1 day (IQR 0–2) for AKI Stage 3.
More patients were admitted to hospital within 7 days of an
AKI episode following introduction of e-alerts: 342 (12.9%) ver-
sus 372 (25.5%), P< 0.001, compared with 2012 prior to e-alert
implementation. Almost double the number of patients with
Stage 1 AKI were admitted to hospital within 7 days following e-
alert implementation (10.9% versus 18.7%).
DISCUSSION
Our results demonstrate that the introduction of e-alerts for AKI
in primary care was associated with higher rates of early repeat
blood sampling. We also found that rates of hospitalization
within 7 days were higher following introduction of e-alerts.
Pre e-alert (2012)             Post e-alert (2015/16) 
8812 
Total AKI episodes 
2650 
Primary Care AKI 
episodes 
9978 
Total AKI episodes 
1460 
Primary Care AKI 
episodes 
150 Excluded 
• 46 non-primary care alerts 
• 39 ‘False’ baseline 
• 19 Dialysis paents 
• 11 Duplicate alert 
• 25 Same AKI episodes





Number of paents 




same AKI episode) 
1205 
Number of paents 
with AKI detected in 
primary care 
FIGURE 1: Flowchart of e-alerts forming study cohorts. Duplicate alert is defined as replicate e-alert with the same patient, date and time. ‘Same AKI episode’ is defined
as e-alert for same patient occurring within 7 days of previous alert or improving AKI stages from initial e-alert.
Table 1. Populations with AKI episodes pre-and post-e-alert introduction
2012 2015–16
Total number of individuals with AKI 6604 5852
Mean age of individuals with AKI (years) (SD) 72.0 (16.1) 71.1 (17.4)
Female sex—individuals with AKI (%) 3328 (50.4) 3124 (53.4)
Total number of AKI episodes 8812 9978
AKI detection sample requested by GP (% of all AKI) 2650 (30.1) 1460 (14.8)
Number of patients with AKI detected from GP sample 2257 1205
Mean age of individuals with AKI from GP sample (years) (SD) 73.4 (14.5) 73.0 (16.9)
Female sex—individuals with AKI from GP sample (%) 1166 (51.7) 706 (58.6)
Diabetes Mellitus (%) 628 (27.8) 320 (26.6)
Congestive Heart Failure (%) 372 (16.5) 201 (16.7)
eGFR<60 mL/min/1.73 m2 (%) 1281 (56.8) 429 (34.5)
GP-detected AKI Stage 1 (percentage of all GP-detected AKI) 2483 (93.7) 1167 (79.9)
GP-detected AKI Stage 2 (percentage of all GP-detected AKI) 110 (4.2) 181 (12.4)
GP-detected AKI Stage 3 (percentage of all GP-detected AKI) 57 (2.1) 112 (7.7)
Table 2. Actions associated with AKI occurrences, pre- and post-
e-alert introduction (number and percentage)
Number (%) 2012 2015–16 P
Number with repeat creatinine within 7 days:
All AKI episodes (%) 252/2650 (9.5) 857/1460 (58.7) <0.001
AKI Stage 1 (%) 235/2483 (9.4) 623/1167 (53.4) <0.001
AKI Stage 2 (%) 13/110 (11.8) 144/181 (79.6) <0.001
AKI Stage 3 (%) 4/57 (7.0) 90/112 (80.4) <0.001
Number admitted to hospital within 7 days:
All AKI episodes (%) 342/2650 (12.9) 372/1460 (25.5) <0.001
AKI Stage 1 (%) 270/2483 (10.9) 218/1167 (18.7) <0.001
AKI Stage 2 (%) 43/110 (39.1) 77/181 (42.5) 0.56
AKI Stage 3 (%) 29/57 (50.9) 77/112 (68.8) 0.02
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The 2009 National Confidential Enquiry into Patient
Outcome and Death report highlighted deficiencies in recogniz-
ing AKI [9]. E-alerts are considered a feasible way to improve
early detection in both hospital and community settings [10,
11], although it has become increasingly evident that in isola-
tion these do not improve patient outcomes [5, 11–14]. However,
e-alerts could be a powerful adjunct in improving mortality and
reducing progression of AKI when coupled with care bundles
and change in clinician behaviour [14, 15]. The implementation
of e-alerts in Tayside was supported by a programme of educa-
tion in both primary and secondary care to increase awareness.
There was subsequent signposting to a specific primary care
AKI guideline, along with an e-mail. This system did not replace
already existing advisory telephone calls from laboratory staff
for significant results.
We found that the total number of AKI episodes in primary
care was significantly higher in 2012 compared with 2015–16
(30.1% versus 14.8%). This may be due to increased awareness
of AKI and use of ‘Medicines Sick Day Rule cards’, which were
also rolled out in 2015–16 in Tayside. This may have also led to
a lower threshold for hospitalization of patients, patients were
being admitted earlier in their illness prior to detection of AKI in
the community. A repeat creatinine was measured early (within
7 days) in 58.7% of the post-e-alert cohort compared with 9.5%
in the pre-e-alert cohort. This suggests that most primary care
physicians are actively responding to the alerts in a timely man-
ner. This is reassuring as a Welsh study has shown that patients
with community-acquired AKI who had an early repeat creati-
nine measurement (<7 days) had better outcomes than those
who had creatinine repeated later (>7 days) [16]. The introduc-
tion of alerts in association with change in clinician behaviour
has recently been shown elsewhere to reduce mortality, length
of hospitalization and rates of dialysis [17]. It has also been
demonstrated that the early detection of AKI in primary care
has the potential to prevent more severe AKI and reduce overall
mortality [13]. This therefore highlights the importance of early
action in patients with AKI detected in the community, and
raises the notion that a clinical review, or referral, together with
a repeat measurement of creatinine within 7 days would be a
prudent response to AKI e-alerts in primary care.
25.5% of patients with AKI detected in the community were
admitted within 7 days, in contrast to 12.9% in the pre-e-alert
cohort. This admission rate is in line with a study by Holmes et
al., who examined e-alerts generated in primary care in a large
Welsh cohort [16]. They found that 22% of patients with AKI
from primary care were admitted to hospital within the same
period [16]. This is despite a smaller number of AKI being
detected in primary care in the post-e-alert cohort (1460 versus
2650) and thus a higher number of AKI cases being detected dur-
ing, or at the point of, hospital admission. One explanation for
this could be greater awareness of the danger of AKI by general
practitioners (GPs), leading to a lower threshold for admitting
patients before their illness progresses to the point where AKI
becomes manifest. An alternative explanation is that our
results reflect a trend of hospitalization for less severe disease
that is unrelated to AKI. Similar trends have been seen in hospi-
talization rates for community-acquired pneumonia; hospitali-
zation rates have risen sharply with no change in severity,
comorbidity or outcomes [18]. Early hospitalization for a range
of illnesses would tend to shift the point of diagnosis for AKI
from community to hospital, but would also explain the higher
rate of hospitalization following a community diagnosis of AKI.
Disentangling the causes for this observation will require fur-
ther studies.
A limitation of our work was that we arbitrarily selected
2012 as the period prior to alert implementation. The increase
in testing may also be related to the differences between these
two populations and increased awareness of AKI unrelated to
the introduction of e-alerts. Examination of another year would
ensure that this year is truly representative of practice prior to
e-alert implementation. A further limitation of our study is that
we are unable to present mortality data. This may have had an
impact on our findings as people may have died prior to repeat
testing. Furthermore, data on mortality would help establish
whether the two populations are comparable. Further work ex-
amining mortality rates and rates of renal progression are re-
quired to establish whether e-alerts have had a beneficial effect
on mortality. We were also unable to electronically interrogate
GP records. Thus, we could not ascertain the clinical actions un-
dertaken by primary care staff. These could have included with-
holding high-risk medicines, advising on hydration, referring to
tertiary renal services or appropriate imaging. It is also impor-
tant to remember that repeated blood sampling might have
been inappropriate for some patients, for example those who
were approaching the end of their lives.
AKI e-alerts can help highlight high-risk patients in the com-
munity, aiding early detection of AKI. We have demonstrated
that their implementation in primary care may have influenced
practice with higher levels of timely, repeat testing. There were,
however, higher rates of hospitalization. Further work focused
on examining the effects of e-alerts on mortality, primary care
prescribing and how they alter primary care clinician behaviour
is necessary to establish their full impact.
Establishing the resultant burden on biochemistry labora-
tory and hospital services also deserves further investigation.
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